Health News

(American Thoracic Society) New research has found that extensively drug-resistant tuberculosis is increasingly common and more deadly than previously known. Extensively drug-resistant tuberculosis is a growing public health threat that is only just beginning to be understood by medical and public health officials.

Read more

Filed under: General Health News
Tags: Drug, General Health News, Tuberculosis

Related posts

• XDR-TB declining in the U.S. (0)
  A new report suggests that the number of cases of extensively drug-resistant tuberculosis (XDR-TB) in the U.S. has declined in the past fifteen years, but new cases continue to be reported, according to the study published in the November 12 issue of JAMA. Read more [tags] General Health News [/tags]
  
  
• WHO Guidelines for Drug-Resistant Tuberculosis Updated (0)
  Guidelines extend treatment duration, call for cost-effective ambulatory models. Medscape Medical News Read more [tags] General Health News [/tags]
  
  
• Teaching an old drug new tricks (0)
  (Johns Hopkins Medical Institutions) A century-old drug that failed in its original intent to treat tuberculosis but has worked well as an anti-leprosy medicine now holds new promise as a potential therapy for multiple sclerosis and other autoimmune diseases. Read more [tags] General Health News [/tags]
  
  
• Substance use common among patients with tuberculosis (0)
  About one in five U.S. tuberculosis patients reports abusing alcohol or using illicit drugs, and those who do appear more contagious and difficult to treat, according to a report in the January 26 issue of Archives of Internal Medicine. Read more [tags] General Health News [/tags]
  
  
• Sequella, Inc. drug compound SQ109 selected for phase 1B clinical trial program (0)
  Sequella, Inc., a clinical-stage biopharmaceutical company focused on diseases of epidemic potential, announced today that SQ109, its lead drug candidate for the treatment of tuberculosis (TB), was the first drug approved for evaluation in a newly awarded clinical program contract to Dynport Vaccine Company LLC and Quintiles Transnational. Read more [tags] General Health News [/tags]